Rifampicin News and Research

RSS
MIP vaccine could reduce new leprosy cases in India by 60%

MIP vaccine could reduce new leprosy cases in India by 60%

Study provides insight into why individual mycobacteria respond differently to antibiotics

Study provides insight into why individual mycobacteria respond differently to antibiotics

New ultra-fast molecular method can help detect mycobacterial pathogens in the lungs

New ultra-fast molecular method can help detect mycobacterial pathogens in the lungs

Cochrane review explores FDCs versus single-drug formulations for treatment of pulmonary TB

Cochrane review explores FDCs versus single-drug formulations for treatment of pulmonary TB

Novel rapid diagnostic test and shorter treatment with better outcomes may benefit MDR-TB patients

Novel rapid diagnostic test and shorter treatment with better outcomes may benefit MDR-TB patients

Health officials to attend International Summit on Tuberculosis and Diabetes in Bali, Indonesia

Health officials to attend International Summit on Tuberculosis and Diabetes in Bali, Indonesia

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

Helsinn's Akynzeo for CINV prevention receives EC approval

Helsinn's Akynzeo for CINV prevention receives EC approval

Boehringer announces LUX-Lung 8 data that compares efficacy of afatinib, erlotinib in patients with advanced SCC

Boehringer announces LUX-Lung 8 data that compares efficacy of afatinib, erlotinib in patients with advanced SCC

New TB-Profiler tool to find appropriate drugs for TB patients may improve likelihood of cure

New TB-Profiler tool to find appropriate drugs for TB patients may improve likelihood of cure

STA, Helsinn announce approval of AKYNZEO for prevention of chemotherapy-induced CINV

STA, Helsinn announce approval of AKYNZEO for prevention of chemotherapy-induced CINV

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

LSTM experts use integrated model to assess effects of new diagnostic algorithms for TB

LSTM experts use integrated model to assess effects of new diagnostic algorithms for TB

Eating food just before taking TB drug could reduce effectiveness of medicine

Eating food just before taking TB drug could reduce effectiveness of medicine

First step toward new drugs that can transcend antibiotic resistance issues

First step toward new drugs that can transcend antibiotic resistance issues

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Xpert MTB/RIF test quickly detects TB and resistance to rifampicin

Xpert MTB/RIF test quickly detects TB and resistance to rifampicin

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets